• 10.26.18

    Would CMS’s Drug Price Transparency Requirement Really Lower Prices?

    On October 15, the Trump Administration’s Centers for Medicare & Medicaid Services (CMS) published a proposed rule that, if finalized, would require prescription drug makers to include prescription drug price information in broadcast advertising. The Administration stated that it ...

  • 09.06.18

    An Insider’s Perspective on Brands, Experiential Entertainment and Innovation

    On the latest edition of the Manatt Digital Podcast, Chris Denson joins the show and lends his expertise to a discussion that covers a wide range of topics, including experiential entertainment, the most disruptive innovations of the past five years, how brands can effectively market to ...

  • 06.20.18

    Podcast: Exploring Growth and Innovation in Music and Data

    In the latest edition of the Manatt Digital Podcast, we explore the worlds of music and data. The music industry is experiencing a strong resurgence in growth thanks to the proliferation of streaming worldwide. Jordan Bromley, a Manatt, Phelps & Phillips partner and one of the top music and ...

  • 05.04.18

    Podcast: Our Lens on the Digital Media Marketplace

    Manatt Digital is excited to introduce a series of podcasts that will include relevant topics and speakers covering the digital media and tech ecosystem. Our upcoming episodes will take a look at digital music, GDPR/privacy for content companies, company highlights and more. For this month’s ...

  • 08.29.17

    Manatt Insights Podcast: Titan Platform CEO Adrian Sexton

    Manatt Digital is firmly dedicated to advancing the collective consciousness as it relates to the future of all things digital. As part of this ongoing effort, we will now be including a podcast as part of our monthly newsletter. Welcome to the newly minted “Manatt Insights” podcast! ...

  • Blue-Capped-Drug-Bottles-on-Conveyor


    The Election’s Impact on Pharma: Preparing for Potential Scenarios

    The 2016 election will have a major impact on both federal and state healthcare policy. To be prepared for all the possibilities, it’s critical to understand the political dynamics that will be in play under each potential scenario—and what they will mean for the life sciences ...



pursuant to New York DR 2-101(f)

© 2021 Manatt, Phelps & Phillips, LLP.

All rights reserved